Certified by Founder
Lodge
Sift Biosciences
start up
United States
- San Carlos, CA
- 19/02/2026
- Pre-Seed
- $3,700,000
Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
- Industry Biotechnology Research
- Website https://siftbio.com/
- LinkedIn https://www.linkedin.com/company/sift-biosciences/
Related People
Yue Clare Lou, Ph.D.Co Founder
United States -
San Francisco Bay Area
Scientist | Founder
Immunology | Cancer <> AI/Bioinformatics <> Microbiology
Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Origin Lab | $8,000,000 | (May 14, 2026)
CREATE Medicines | $122,000,000 | (May 14, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)
Saile Medical (Saile App) | $2,200,000 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)